This page is specifically intended to support patients who have been prescribed Gilenya by a UK healthcare provider. If you have any questions about your medication, ask your doctor, nurse or pharmacist and read the patient information leaflet provided with your medicine.

 

       

What to expect when starting Gilenya

A video to show you what to expect when starting treatment with Gilenya.

Watch

Patient booklet

A booklet which gives you important information about taking Gilenya as well as practical advice about staying healthy while on treatment.

Download

The young person’s guide to Gilenya

A booklet to help paediatric patients prescribed Gilenya to understand more about treatment with Gilenya.

Download

 

 

Summary of product characteristics (SPC) for Gilenya

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.

 

Patient information leaflet (PIL) for Gilenya

This link will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.

 

Resources for MS patients

Download our range of resources designed to support you with your MS.

 

Image of MS relapse recorder

MS relapse recorder

A resource for you to record and track your MS symptoms.

Download

Image of phone with Symtrac app

SYMTRAC™

A free Novartis app to help you keep track of your MS, which includes exercises to do at home.

Download for Android

Download for Apple

Cover image of Recognising your MS symptoms guide

Recognising your MS symptoms

A guide to help you recognise MS symptoms and what to do if you think you’re having a relapse.

Download

 

You can find out more about MS, including support and information for MS patients, on the websites of the following organisations:

 

This link will take you to the Living Like You website, which is a Novartis website.

 

Image of Living like you logo

 

These links will take you to the Multiple Sclerosis Trust, MS Society or Shift.ms websites, which are non-Novartis websites.

 Image of MS Trust logo

Multiple Sclerosis Trust

 Image of MS Society logo

MS Society

 Image of Shift.ms logo

Shift.ms

 

 

MS, multiple sclerosis.

GIL19-C053k November 2020.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See yellowcard.mhra.gov.uk for how to report side effects.

 

×

Ask Speakers

×

Medical Information Request

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You should also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk.
By reporting side effects you can help provide more information on the safety of this medicine.